These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7465198)

  • 41. [Gilbert's syndrome (Crigler-Najjar syndrome)].
    Yamamoto T; Adachi Y
    Nihon Rinsho; 1977; 35 Suppl 1():870-1. PubMed ID: 613033
    [No Abstract]   [Full Text] [Related]  

  • 42. Persistant unconjugated hyperbilirubinemia in an infant with crigler-najjar syndrome type I.
    Kulkarni ML; C NR
    Indian Pediatr; 2003 Dec; 40(12):1209-10. PubMed ID: 14722376
    [No Abstract]   [Full Text] [Related]  

  • 43. [Phototherapy: current concepts].
    Vargas-Origel A; Jasso-Gutiérrez L
    Bol Med Hosp Infant Mex; 1984 Jan; 41(1):7-14. PubMed ID: 6367770
    [No Abstract]   [Full Text] [Related]  

  • 44. [Crigler-Najjar syndrome in an infant during the 1st year of life].
    Volodin NN
    Pediatriia; 1991; (9):100-2. PubMed ID: 1754338
    [No Abstract]   [Full Text] [Related]  

  • 45. [The Crigler-Najjar syndrome, type I. Therapeutic dilemmas].
    Jesić M; Maglajlić S
    Srp Arh Celok Lek; 2000; 128(11-12):389-92. PubMed ID: 11337919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of deafness in Crigler-Najjar syndrome type 1: a patient survey.
    Suresh G; Lucey JF
    Pediatrics; 1997 Nov; 100(5):E9. PubMed ID: 9347003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of treatments for congenital nonobstructive nonhaemolytic hyperbilirubinaemia.
    Arrowsmith WA; Payne RB; Littlewood JM
    Arch Dis Child; 1975 Mar; 50(3):197-201. PubMed ID: 1147651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crigler-Najjar syndrome II and pregnancy outcome.
    Sagili H; Pramya N; Jayalaksmi D; Rani R
    J Obstet Gynaecol; 2012 Feb; 32(2):188-9. PubMed ID: 22296437
    [No Abstract]   [Full Text] [Related]  

  • 49. Phototherapy in nonobstructive, nonhemolytic jaundice.
    Altay C; Say B
    Pediatrics; 1973 Jan; 51(1):124-6. PubMed ID: 4684432
    [No Abstract]   [Full Text] [Related]  

  • 50. Removal of protein-bound and unbound unconjugated bilirubin by perfusion of plasma through an anion-exchange resin in a case of Crigler-Najjar syndrome type I.
    Ihara H; Shino Y; Hashizume N; Shimizu N; Aoki T; Yoshida M
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):528-33. PubMed ID: 14503990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvements in long term phototherapy for patients with Crigler-Najjar syndrome type I.
    Job H; Hart G; Lealman G
    Phys Med Biol; 1996 Nov; 41(11):2549-56. PubMed ID: 8938045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age eighteen.
    Blaschke TF; Berk PD; Scharschmidt BF; Guyther JR; Vergalla JM; Waggoner JG
    Pediatr Res; 1974 May; 8(5):573-90. PubMed ID: 4825526
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatocytes immobilised by microencapsulation in artificial cells: effects on hyperbilirubinemia in Gunn rats.
    Bruni S; Chang TM
    Biomater Artif Cells Artif Organs; 1989; 17(4):403-11. PubMed ID: 2605354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of different types of jaundice.
    Arias JM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():2029-39. PubMed ID: 1030162
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.
    Fox IJ; Chowdhury JR; Kaufman SS; Goertzen TC; Chowdhury NR; Warkentin PI; Dorko K; Sauter BV; Strom SC
    N Engl J Med; 1998 May; 338(20):1422-6. PubMed ID: 9580649
    [No Abstract]   [Full Text] [Related]  

  • 56. Type 2 Crigler-Najjar syndrome. Quantitation of ultrastructural data and evolution under therapy with phenytoin.
    Koch MM; Lorenzini I; Freddara U; Jezequel AM; Orlandi F
    Gastroenterol Clin Biol; 1978 Oct; 2(10):831-42. PubMed ID: 729981
    [No Abstract]   [Full Text] [Related]  

  • 57. Bilirubin photoisomerization products in serum and urine from a Crigler-Najjar type I patient treated by phototherapy.
    Agati G; Fusi F; Pratesi S; Galvan P; Donzelli GP
    J Photochem Photobiol B; 1998 Dec; 47(2-3):181-9. PubMed ID: 10093917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proceedings: Prolonged survival in the Crigler-Najjar syndrome: ultrastructural and dietary studies.
    Gollan JL; Huang SN; Billing BH; Sherlock S
    Gut; 1974 Oct; 15(10):838. PubMed ID: 4434967
    [No Abstract]   [Full Text] [Related]  

  • 59. Effective phototherapy in congenital nonobstructive, nonhemolytic jaundice.
    Karon M; Imach D; Schwartz A
    N Engl J Med; 1970 Feb; 282(7):377-80. PubMed ID: 5411133
    [No Abstract]   [Full Text] [Related]  

  • 60. Tin-protoporphyrin in the management of children with Crigler-Najjar disease.
    Rubaltelli FF; Guerrini P; Reddi E; Jori G
    Pediatrics; 1989 Oct; 84(4):728-31. PubMed ID: 2780137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.